
Meet Heather N. Sugrue
Heather N. Sugrue is the founder of Chrysalys Bio and a passionate advocate for helping CDMOs operate the right way—ethically, practically, and with both purpose and profit.
She believes CDMO success isn’t about capacity or contracts alone. It’s about building an environment where every part of the organization is aligned, collaborative, and equipped to deliver—internally and externally. In drug development, that alignment isn’t a luxury. It’s what enables teams to meet commitments, grow revenue, and ultimately bring life-changing therapies to patients.
With two decades of in-house experience at leading CDMOs—including Patheon, Bend Biosciences (formerly Recro), Syngene, Catalent and Matica—Heather has built commercial infrastructure from the ground up. She’s led efforts to strengthen business development strategy, improve internal alignment, and streamline execution across functions. Her work consistently delivered stronger pipelines, faster turnaround times, and more reliable revenue performance—laying the foundation for the frameworks she now brings to clients through Chrysalys Bio.
Heather’s approach is hands-on, honest, and deeply rooted in long-term sustainability. She founded Chrysalys Bio to give CDMOs the clarity and structure they need to evolve with confidence. The results are clear: improved trust, stronger systems, and measurable revenue impact.